Abiraterone CAS NO.154229-19-3
| Nomen | Abiraterone | ||
| CAS NO. | 154229-19-3 | ||
| Formulae hypotheticae | C24H31NO | M. Pondus | 349.52 |
| MDL No. | MCD00924100 | EINECS | 810-941-6 |
| MP | 227-228 °C(Solv: toluene (108-88-3)) | BP | 500.2±50.0 °C (Predicta) |
| Densitas | 1.14g/cm3(Predicta) | Index refractivus | NA |
| FP | NA | Repono conditione | 2-8°C |
| Aspectus | alba vel pallide lutea solida | ||
| Puritas | 98% | ||
| Applicationem | Abiraterone est curatio cancer prostatae | ||
| Facultates copia | Abiraterone CAS NO.154229-19-3 productio nostra regulariter est productio, sive exiguo exemplo sive magna mercium plurium quam tonnagiorum indiges, nostra societas eam formaliter supplere potest. | ||
| Si interest in Abiraterone CAS NO.154229-19-3, libenter tange nos, quaeso, et praestabimus tibi optimam qualitatem productorum, rationabilem pretium et optimum servitium, exspectantes cooperationem nostram. | |
| | |
| Phone No. | +86 139 6251 3054 +86 136 2174 3828 |
Producta, quae a consortio recensentur, patentes implicant, quae tantum ad investigationes et progressus et non venales sunt;fructus moderati vendentur stricte obsequio cum legibus Sinensium et legibus regionis ubi mercantur, et omnia producta usui humano non apta sunt.Si venditae patentes praeiudicium constituent, omnia pericula ab emptore ferentur.
Epistulam tuam hic scribe et mitte nobis
![4-[(4-Methylpiperazin-1-yl) methyl]acidi dihydrochloridi benzoici CAS NO.106261-49-8](http://cdn.globalso.com/shlzpharma/106261-49-8-1.jpg)
![(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluorpentyl)Thio]Nonyl]-Estra-1,3,5(10)-Triene-3,17-Diol 17- ACETATIS CAS NO.875573-69-6](http://cdn.globalso.com/shlzpharma/127.png)
![6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-unus CAS NO.1016636-76-2](http://cdn.globalso.com/shlzpharma/129.png)
